Shukra Pharmaceuticals Limited (BOM:524632)
India flag India · Delayed Price · Currency is INR
28.09
+0.86 (3.16%)
At close: May 27, 2026

Shukra Pharmaceuticals Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
May '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
11,97113,2859,5683,57551495
Market Cap Growth
109.65%38.86%167.65%595.01%443.89%35.73%
Enterprise Value
11,96113,1899,4153,504520199
Last Close Price
27.2330.3421.848.031.150.31
PE Ratio
54.4660.2399.9219.2811.6712.60
PS Ratio
21.1023.4229.364.790.870.46
PB Ratio
13.3214.7915.236.202.030.58
P/TBV Ratio
13.3214.7915.236.202.030.58
P/FCF Ratio
--184.87--1.47
P/OCF Ratio
304.50337.94120.83-16.231.18
EV/Sales Ratio
21.0923.2528.894.700.880.97
EV/EBITDA Ratio
35.8939.5860.9116.188.016.78
EV/EBIT Ratio
40.0344.1475.6117.8711.1715.63
EV/FCF Ratio
-101.37-181.91--3.09
Debt / Equity Ratio
0.060.060.070.060.200.21
Debt / EBITDA Ratio
0.150.150.270.150.781.15
Debt / FCF Ratio
--0.81--0.52
Net Debt / Equity Ratio
-0.01-0.01-0.13-0.120.040.19
Net Debt / EBITDA Ratio
-0.03-0.03-0.51-0.310.171.05
Net Debt / FCF Ratio
0.080.08-1.530.98-0.840.48
Asset Turnover
0.560.560.400.981.080.58
Inventory Turnover
1.331.331.3516.2812.783.73
Quick Ratio
1.251.252.332.891.000.62
Current Ratio
3.633.633.793.971.251.28
Return on Equity (ROE)
28.89%28.89%15.90%44.70%21.16%4.70%
Return on Assets (ROA)
18.29%18.29%9.46%16.04%5.29%2.25%
Return on Invested Capital (ROIC)
31.56%31.85%16.91%47.35%20.16%4.24%
Return on Capital Employed (ROCE)
31.70%31.70%17.90%30.80%14.40%5.60%
Earnings Yield
1.84%1.66%1.00%5.19%8.57%7.94%
FCF Yield
-0.99%-0.89%0.54%-1.95%-2.57%68.08%
Dividend Yield
0.04%0.03%0.05%1.24%1.09%4.06%
Payout Ratio
1.99%1.98%45.73%0.38%1.65%-
Buyback Yield / Dilution
-0.75%-0.75%--551.03%-7.38%-
Total Shareholder Return
-0.72%-0.72%0.05%-549.78%-6.29%4.06%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.